APA (7th ed.) Citation

O’Neill, M. J., Yoneda, Z. T., Crawford, D. M., Ye, F., Ao, M., Pitchford, L. M., . . . Shoemaker, M. B. (2021). 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: Protocol for a randomized controlled trial including detection of AF using a wearable device. Current controlled trials in cardiovascular medicine, 22(1), 576-13. https://doi.org/10.1186/s13063-021-05553-6

Chicago Style (17th ed.) Citation

O’Neill, Matthew J., et al. "2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter Ablation: Protocol for a Randomized Controlled Trial Including Detection of AF Using a Wearable Device." Current Controlled Trials in Cardiovascular Medicine 22, no. 1 (2021): 576-13. https://doi.org/10.1186/s13063-021-05553-6.

MLA (9th ed.) Citation

O’Neill, Matthew J., et al. "2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter Ablation: Protocol for a Randomized Controlled Trial Including Detection of AF Using a Wearable Device." Current Controlled Trials in Cardiovascular Medicine, vol. 22, no. 1, 2021, pp. 576-13, https://doi.org/10.1186/s13063-021-05553-6.